Related Experiment Video
Updated: Jun 14, 2025

Deacetylation Assays to Unravel the Interplay between Sirtuins SIRT2 and Specific Protein-substrates
Published on: February 27, 2016
Activation and inhibition of sirtuins: From bench to bedside
Francesco Fiorentino1, Emanuele Fabbrizi1, Antonello Mai1,2
1Department of Drug Chemistry and Technologies, Sapienza University of Rome, Rome, Italy.
Abstract:
The sirtuin family comprises seven NAD+-dependent enzymes which catalyze protein lysine deacylation and mono ADP-ribosylation. Sirtuins act as central regulators of genomic stability and gene expression and control key processes, including energetic metabolism, cell cycle, differentiation, apoptosis, and aging. As a result, all sirtuins play critical roles in cellular homeostasis and organism wellness, and their dysregulation has been linked to metabolic, cardiovascular, and neurological diseases. Furthermore, sirtuins have shown dichotomous roles in cancer, acting as context-dependent tumor suppressors or promoters. Given their central role in different cellular processes, sirtuins have attracted increasing research interest aimed at developing both activators and inhibitors. Indeed, sirtuin modulation may have therapeutic effects in many age-related diseases, including diabetes, cardiovascular and neurodegenerative disorders, and cancer. Moreover, isoform selective modulators may increase our knowledge of sirtuin biology and aid to develop better therapies. Through this review, we provide critical insights into sirtuin pharmacology and illustrate their enzymatic activities and biological functions. Furthermore, we outline the most relevant sirtuin modulators in terms of their modes of action, structure-activity relationships, pharmacological effects, and clinical applications.
Insights
Sirtuins, NAD+-dependent enzymes, regulate key cellular processes and aging. Modulating sirtuins offers therapeutic potential for metabolic, cardiovascular, and neurodegenerative diseases, and cancer.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Sirtuins are NAD+-dependent enzymes regulating genomic stability, gene expression, metabolism, and aging.
- Dysregulation of sirtuins is implicated in metabolic, cardiovascular, neurological diseases, and cancer.
- Sirtuins exhibit context-dependent roles in cancer, acting as tumor suppressors or promoters.
Purpose of the Study:
- To provide critical insights into sirtuin pharmacology, enzymatic activities, and biological functions.
- To review relevant sirtuin modulators, including their mechanisms, structure-activity relationships, and effects.
- To discuss the therapeutic potential of sirtuin modulation in age-related diseases and cancer.
Main Methods:
- Literature review of sirtuin biology and pharmacology.
- Analysis of enzymatic activities and biological functions of sirtuins.
- Overview of structure-activity relationships and pharmacological effects of sirtuin modulators.
Main Results:
- Sirtuins are crucial for cellular homeostasis and organism wellness.
- Sirtuin modulation shows therapeutic promise for diabetes, cardiovascular/neurodegenerative disorders, and cancer.
- Isoform-selective modulators can advance understanding of sirtuin biology and therapeutic development.
Conclusions:
- Sirtuin modulators represent a promising therapeutic strategy for various diseases.
- Further research into isoform-selective sirtuin modulators is warranted.
- Understanding sirtuin pharmacology is key to developing effective treatments for age-related conditions and cancer.
Related Concept Videos
The JAK-STAT Signaling Pathway
Inhibition of Cdk Activity
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...

